Biosimilar Newsletter Archive

31. 08.02.18 -- Samsung Bioepis: From Biosimilars To Novel Biologics
    8/2/2018

    08/02/18 Biosimilar Development Newsletter

32. 07.26.18 -- 3 Biosimilar Market Access Experiences
    7/26/2018

    07/26/18 Biosimilar Development Newsletter

33. 07.19.18 -- 4 Conversations Integral To Biosimilar Partnerships
    7/19/2018

    07/19/18 Biosimilar Development Newsletter

34. 07.12.18 -- Lit Review Pushback Highlights Areas For Future Study
    7/12/2018

    07/12/18 Biosimilar Development Newsletter

35. 07.05.18 -- FDA's Latest Move Worthy Of Celebration
    7/5/2018

    07/05/18 Biosimilar Development Newsletter

36. 06.29.18 -- Downstream Virus Purification Platforms
    6/29/2018
    06/29/18 Biosimilar Development Newsletter
37. 06.27.18 -- Cell Therapy Solutions For Every Step
    6/27/2018
    06/27/18 Biosimilar Development Newsletter
38. 06.20.18 -- Ways To Expand Capacity In Buffer Management
    6/20/2018
    06/20/18 Biosimilar Development Newsletter
39. 06.14.18 -- How Biosimilars Can Win Over U.S. Payers
    6/14/2018
    06/14/18 Biosimilar Development Newsletter
40. 06.07.18 -- Key Learnings Shaping Pfizer’s Biosimilar Business
    6/7/2018
    06/07/18 Biosimilar Development Newsletter